Physician profile
Robert E Winsett
NPI 1841633153
$1,748.14
in general payments reported to CMS, 2019-2025
19 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $29.07 · 2021: $60.71 · 2022: $87.58 · 2023: $282 · 2024: $611 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $382.14 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.62 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $225.02 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Insmed, INC. | $224.92 | 2019-2024 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $206.03 | 2019-2024 | Fasenra, Airsupra |
| Merck Sharp & Dohme LLC | $84.19 | 2019-2024 | Winrevair |
| Tactile Systems Technology INC | $59.95 | 2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $48.55 | 2023 | |
| Baxter Healthcare | $40.34 | 2022-2024 | Hillrom - Monarch Airway Clearance System |
| Advanced Respiratory, INC | $37.62 | 2021 | |
| Pfizer INC. | $37.59 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.11 | 2019 | |
| Genzyme Corporation | $25.80 | 2024 | |
| Monaghan Medical Corporation | $21.43 | 2023 | Aeroeclipse |
| Vapotherm INC | $20.47 | 2024 | Vapotherm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.54 | 2019 | |
| Chiesi USA, INC. | $15.01 | 2019 | |
| Melinta Therapeutics, LLC | $14.68 | 2019 | |
| Mylan Specialty L.P. | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Winsett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.